Ocrevus approved for RRMS in England and Wales on: June 22, 2018, 10:19:53 am #1 From the Multiple Sclerosis Trust, this announcement that NICE has approved Ocrevus for RRMS with certain restrictions: Ocrevus (ocrelizumab) Ocrevus (ocrelizumab) is a disease modifying drug treatment for relapsing remitting and early primary progressive MS. It is taken as an infusion into a vein or an injection under the skin every six... MS Trust · mstrust.org.uk Last Edit: June 29, 2018, 09:14:52 pm by agate Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
"England's cost watchdogs shoot down Ocrevus for PPMS" (from FiercePharma) Reply #1 on: June 29, 2018, 09:17:32 pm #2 More on this from FiercePharma, June 29, 2018: England's cost watchdogs shoot down Roche's Ocrevus, the only approved therapy for PPMS Roche’s Ocrevus (ocrelizumab) may be the only approved treatment for primary progressive multiple sclerosis, a tough-to-treat form of the disease. | Roche’s Ocrevus may be the only approved tre... Fierce Pharma · fiercepharma.com Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
